Wayrilz 400 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FQR3W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,552
Award facts
- Contract value 100% obligated
- $23,552.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Vraylar 400 mg tablets (60-count units) under a firm fixed-price contract valued at $23,552.36, with an ultimate completion date of December 24, 2025. This non-set-aside delivery order represents a competitive award to the pharmaceutical distributor and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, a comprehensive $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical commodities to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs, particularly supporting Defense Health Agency and military healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering both brand-name and generic medications across multiple therapeutic domains, including neurological treatments, diabetes medications, pain management pharmaceuticals, and specialized medical supplies. This delivery order for Vraylar, a neuropsychiatric medication, aligns with the company's established role as a primary pharmaceutical supplier within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FQR3W?
SPE2DR26FQR3W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FQR3W worth?
The government has obligated $23,552 on SPE2DR26FQR3W.
Is contract SPE2DR26FQR3W an order under another contract?
Yes. SPE2DR26FQR3W is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQR3W competed?
The extent of competition for SPE2DR26FQR3W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award